Smita Nimkar, MSc

Pune, India
Role: 
Staff
Study Coordinator & Regulatory Coordinator

Smita Nimkar is Study Coordinator for TREATAsia studies, and Regulatory Coordinator &  IRB/EC Liaison for the clinical research site (CRS) at BJ Government Medical College (BJGMC) in Pune, India. The BJGMC CRS is part of the JHU Baltimore- India Clinical Trials Unit (JHUBI-CTU), which conducts clinical trials under the NIH ACTG and IMPAACT Trial Networks—along with the Johns Hopkins CRS (Baltimore, MD). She works with the India research team to ensure training on and compliance with scientific regulatory standards at all levels. She is a Director of the Training and Education Committee of JHUBI.  She is serving on various ACTG committees. Smita has worked in healthcare for more than 20 years, and her experience includes HIV/AIDS, TB, and other comorbidities. She has implemented several research projects on mental health, and communicable and non-communicable diseases. Currently, she is a trainee ESI under Fogarty-IeDEA Mentorship Program (FIMP) from Asia-Pacific region.

 

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis

Post Date: 
2017-12-07
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
PLOS One
PLOS One: Mave and colleagues compared TB drug exposure in plasma and hair samples among a small cohort of children.

Tuberculosis screening among persons with diabetes mellitus in Pune, India

Post Date: 
2017-06-02
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
BMC Infectious Diseases
Background: Diabetes mellitus (DM) increases tuberculosis (TB) risk, and there is increasing concern over the public health implications of the convergence of these two epidemics. Screening for TB among people with DM is now recommended in India. Methods: People with DM seeking...

Isoniazid hair concentrations in children with tuberculosis: a proof of concept study

Post Date: 
2016-06-01
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
International Journal of Tuberculosis and Lung Disease
Assessing treatment adherence and quantifying exposure to anti-tuberculosis drugs among children is challenging. We undertook a 'proof of concept' study to assess the drug concentrations of isoniazid (INH) in hair as a therapeutic drug monitoring tool. Children aged <12 years initiated on...

Pages